This paper compared total and fetal cell-free DNA (cfDNA) levels before and after frozen storage of plasma or extracted cfDNA. The authors also investigated if frozen storage of plasma negated the need for Proteinase K treatment.
Impact of long-term storage of plasma and cell-free DNA on measured DNA quantity and fetal fraction.
Clausen FB, Barrett AN, Advani HV, Choolani M, Dziegiel MH
Purpose
Conclusion
Levels of cfDNA were higher from plasma stored for 2 or 3 years at -25°C than in matched plasma prior to storage, but cfDNA levels were lower than before storage when plasma was stored at -25°C for 4 years. The Proteinase K step was necessary for PCR success in fresh specimens, increased amplification of total and fetal DNA from plasma stored 0-1 years, and increased amplification of total cfDNA from specimens stored for 2-4 years to a lesser extent, but did not improve amplification of fetal cfDNA from specimens stored for 2-4 years. Dilution of cfDNA showed the expected concentration of cfDNA, indicating the absence of PCR inhibitors. Quantifiable levels of total and fetal cfDNA increased slightly when extracted cfDNA was stored at -25°C, but the difference in the median percentage of fetal DNA only increased significantly after storage for 3 years.
Studies (2)
Purpose
This study compared total and fetal cell-free DNA levels before and after frozen storage of plasma. The authors also investigated if frozen storage of plasma negated the need for Proteinase K treatment. Blood was collected from 371 pregnant women into K3EDTA tubes. Plasma was obtained by centrifugation at 1700 x g for 10 min within 2-7 days of blood collection and transferred to screw-cap tubes. cfDNA was extracted from plasma immediately and again after storage for <6 months to 6 years at -25°C. Plasma was centrifuged at 6000 x g for 10 min before cfDNA extraction using the QIAsymphony DSP Virus/Pathogen Midi Kit with carrier RNA. The effect of proteinase K was investigated by extracting cfDNA from 20 fresh plasma specimens and 67 stored plasma specimens with the Proteinase K step or using PBS instead of Proteinase K. cfDNA was quantified by real-time PCR amplification of RHD exons 7 and 10 and total cfDNA by amplification of glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The presence of PCR inhibitors was investigated by amplification of diluted (1:3) and undiluted cfDNA from 119 specimen pairs.
Summary of Findings
Levels of cfDNA were 112% and 40% higher from plasma stored for 2 and 3 years at -25°C than in matched plasma prior to storage (P<0.0001 and P=0.0013, respectively), but cfDNA levels were lower than before storage when plasma was stored at -25°C for 4 years (P<0.0001). The percentage fetal DNA varied between 1.3 and 6.7% and was generally very strongly correlated between immediately processed and stored specimens (r=0.91-0.93), with the exception of specimens stored for 4 years (r=0.86). However, there was a significant difference in fetal cfDNA between specimens stored for 1 and 3-6 years. Dilution of cfDNA showed the expected concentration of cfDNA, indicating the absence of PCR inhibitors and a very strong correlation in the percentage fetal DNA before and after dilution (r=0.98). When extraction was performed without Proteinase K in fresh specimens, amplification of CCR5 was only possible in 11 of 20 specimens and amplification of SRY in 3 of 19 specimens. Similarly, extraction without Proteinase K in specimens stored for 0 and 1 years resulted in significant less amplification (P<0.0001 and P=0.0015, respectively). In specimens stored for 2-4 years, amplification of fetal DNA was comparable with or without Proteinase K in the extraction, but the total DNA levels were still lower when not Proteinase K treated, though the difference was smaller in specimens stored for 2-4 years than 0-1 years.
Biospecimens
FluidPlasmaPreservation Types
FrozenDiagnoses
PregnantPlatforms
DNAReal-time qPCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Storage Storage duration 0 years1 years2 years3 years4 years5 years6 yearsAnalyte Extraction and Purification Protein digestion No proteinase K addedProteinase K addedReal-time qPCR Specific Targeted nucleic acid GAPDHRHD exons 7 and 10Real-time qPCR Specific Template/input amount Diluted 1:3Undiluted
Purpose
The purpose of this study was to investigate the effects of storage at -25°C on quantifiable total and fetal cfDNA. Blood was collected into K3EDTA tubes and plasma was obtained within 4 h (details not provided). Sixty-seven matched plasma specimens were stored at -80°C until cfDNA extraction using the QIAamp Circulating Nucleic Acid Kit. cfDNA was quantified immediately after extraction and again after 18 months (57 specimens) or 3 years (10 specimens) of storage at -25°C. Fetal cfDNA was quantified by real-time PCR amplification of RHD exons 7 and 10 and total cfDNA by amplification of glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
Summary of Findings
Quantifiable levels of total cfDNA increased slightly when extracted cfDNA was stored for 18 months at -25°C (0.35 and 0.27 ng/µL, P=0.0202). Similarly, quantifiable levels of fetal cfDNA increased slightly when extracted cfDNA was stored for 18 months at -25°C (0.37 ng/µL versus 0.36 ng/µL, P=0.0091), but the percentage of fetal DNA was unaffected. In an additional 10 specimens, quantifiable levels of total and fetal cfDNA increased slightly when extracted cfDNA was stored for 3 years at -25°C (P=0.002, both) and the median fetal fraction increased from 15.6 to 19.8% (P=0.0195).
Biospecimens
FluidPlasmaPreservation Types
FrozenDiagnoses
PregnantPlatforms
DNAReal-time qPCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Storage Storage duration 0 months18 months3 yearsReal-time qPCR Specific Targeted nucleic acid GAPDHRHD Exons 6 and 7